| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/15/2004 | CA2500065A1 Sustained release porous microparticles for inhalation |
| 04/15/2004 | CA2500062A1 Fast-release administration form with slightly soluble active ingredient |
| 04/15/2004 | CA2495055A1 17.beta.-estradiol/levonorgestrel transderm patch for hormone replacement therapy |
| 04/15/2004 | CA2477181A1 Electroactive polymer actuated medication infusion pumps |
| 04/14/2004 | EP1408034A1 Use of Quinoline derivatives as antibacterial agents |
| 04/14/2004 | EP1407795A2 Nasal delivery devices |
| 04/14/2004 | EP1407786A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 04/14/2004 | EP1407785A1 Medicinal compositions |
| 04/14/2004 | EP1407780A1 Pharmaceutically stable hemostatic compositions |
| 04/14/2004 | EP1407776A1 A pharmaceutical colloidal preparation comprising hyaluronic acid biopolymers useful in the treatment of respiratory diseases |
| 04/14/2004 | EP1407775A1 Medical preparation for parenteral injection |
| 04/14/2004 | EP1407766A2 Pharmaceutical compositions that contain a salt of alendronic acid |
| 04/14/2004 | EP1407765A1 Vesicles with chimeric receptors to induce a targeted T-cell response in vivo |
| 04/14/2004 | EP1407764A1 Implants for administering substances and methods of producing implants |
| 04/14/2004 | EP1407761A1 Stable hydroalcoholic compositions |
| 04/14/2004 | EP1407732A1 Eye applicable device for secure dosage of systemic and topic medication |
| 04/14/2004 | EP1407267A2 Gel compositions |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1406995A1 Azeotrope-like compositions of tetrafluoroethane pentafluoropropane, methylbutane and water |
| 04/14/2004 | EP1406915A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 04/14/2004 | EP1406728A1 Process for activation of drugs in a vibrational mill |
| 04/14/2004 | EP1406699A1 Antitumoral formulations of thioxanthenone |
| 04/14/2004 | EP1406678A1 Drug delivery matrices to enhance wound healing |
| 04/14/2004 | EP1406663A2 Vegetable polymer-based composition that immobilises active agents |
| 04/14/2004 | EP1406662A1 Pharmaceutical formulation for the intramuscular administration of fulvestrant |
| 04/14/2004 | EP1406661A1 Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
| 04/14/2004 | EP1406658A1 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 04/14/2004 | EP1406647A1 Use of antimicrobial peptides as preservatives in ophthalmic preparations including solutions emulsions and suspensions |
| 04/14/2004 | EP1406637A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 04/14/2004 | EP1406635A2 A controlled release anti-inflammatory formulation and a process for the preparation thereof |
| 04/14/2004 | EP1406633A1 Enhanced drug delivery in transdermal systems |
| 04/14/2004 | EP1406630A1 Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/14/2004 | EP1406616A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 04/14/2004 | EP1406604A2 Topical application of muscarinic analgesic drugs such as neostigmine |
| 04/14/2004 | EP1406600A1 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 04/14/2004 | EP1406598A1 Lymphatic drug delivery system |
| 04/14/2004 | EP1406597A1 Controlled drug delivery systems providing variable release rates |
| 04/14/2004 | EP1406596A1 Zero order controlled drug delivery system |
| 04/14/2004 | EP1406595A1 Chewable product including active ingredient |
| 04/14/2004 | EP1406594A1 Controlled agglomeration |
| 04/14/2004 | EP1406593A2 Biodegradable polymer compositions, compositions and uses related thereto |
| 04/14/2004 | EP1406592A2 A salt/ion pair medicinal aerosol formulation |
| 04/14/2004 | EP1406591A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 04/14/2004 | EP1406590A1 Method for producing articles consisting of polymer materials having a medicamentous depot effect |
| 04/14/2004 | EP1406571A2 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 04/14/2004 | EP1406568A1 Sequential drug delivery systems |
| 04/14/2004 | EP1406513A1 Protein-containing foodstuff comprising a cross-linking enzyme and a hydrocolloid |
| 04/14/2004 | EP1406496A1 Method and composition for enhancing sexual desire |
| 04/14/2004 | EP1406495A1 Method for reducing muscle fatigue through administration of adenosine triphosphate |
| 04/14/2004 | EP1406493A1 Administration of agents via the pept-2 transporter |
| 04/14/2004 | EP1351696A4 Composition for delivery of hematopoietic growth factor |
| 04/14/2004 | EP1210361B1 Stabilisation of freeze-dried cake |
| 04/14/2004 | EP1183538B1 Cyclodextrin polymers for use as drug carriers |
| 04/14/2004 | EP1181038B1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 04/14/2004 | EP1137406B1 Transdermal patch for delivering volatile liquid drugs |
| 04/14/2004 | EP1131071B1 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
| 04/14/2004 | EP1105399B1 Carboxylated phosphatidic acid esters |
| 04/14/2004 | EP1100477B1 Patch comprising wool fat or its components and zinc oxide, suitable for the transdermal administration of estradiol |
| 04/14/2004 | EP1039917B1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 04/14/2004 | EP1035779A4 Improved chewing gum formulations including aspartame and sodium bicarbonate |
| 04/14/2004 | EP1019361B1 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes |
| 04/14/2004 | EP0993337B1 Hydrophilic polymeric material and method of preparation |
| 04/14/2004 | EP0748213B1 Methods and compositions for pulmonary delivery of insulin |
| 04/14/2004 | EP0525199B2 Composition containing ultrafine particles of magnetic metal oxide |
| 04/14/2004 | CN2610947Y Far infrared anionic plaster |
| 04/14/2004 | CN2610916Y Magnetic plaster with medicine |
| 04/14/2004 | CN1489597A N-oxy-group-contained lipids |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489573A Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
| 04/14/2004 | CN1489480A Procedure and composition of treatment and/or care of eye |
| 04/14/2004 | CN1489478A Medicine preparations for diagnosing infection with helicobacter pyloni |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489474A Monoclonal antibodies to CLFA protein and method of use in treating or preventing |
| 04/14/2004 | CN1489468A Steroid hormone products and preparing method thereof |
| 04/14/2004 | CN1489466A Parenteral dosage containing epothilones |
| 04/14/2004 | CN1489463A Novel crystal forms of atorvastatin hemi-calcium and process for their preparation as well as novel process for preparing other forms |
| 04/14/2004 | CN1489459A Use of 2-amino-1 (4-hydroxy-2-methanesu/phonamidophenyl) ethanol for treating urinary incontinence |
| 04/14/2004 | CN1489457A Clear and stable propofol composition |
| 04/14/2004 | CN1489456A Pharmacentical formulation |
| 04/14/2004 | CN1489455A Delayed release pharmaceutical formulations |
| 04/14/2004 | CN1489438A Water soluble powders and tablets |
| 04/14/2004 | CN1488678A Method for preparing elastomer based on silioxane |
| 04/14/2004 | CN1488403A Calcium alginate/poly arginine-chitin glycan composite medicine release -controlled microcap sule and preparing method thereof |
| 04/14/2004 | CN1488402A Novel medicinal use of proteinase inhibior for preventing and curing lang disease |
| 04/14/2004 | CN1488400A Preparation for preventing and curing endometritis for dairy cattle and preparing method thereof |
| 04/14/2004 | CN1488398A Instant freeze-dried fibriogen preparation with anti dry heat treatment |
| 04/14/2004 | CN1488396A Chinese medicine for treating asynodia |
| 04/14/2004 | CN1488395A Java brucea oil-emulsion injecta with low-toxicity and preparing method thereof |
| 04/14/2004 | CN1488394A Chinese medicine cap sule for treating prostatic disorders |
| 04/14/2004 | CN1488392A Chinese medicine composition for accessory treatment of primary liver cancer and preparing method thereof |
| 04/14/2004 | CN1488385A Chinese medicine composition for treating climacteric metancholia for women and preparing method thereof |
| 04/14/2004 | CN1488384A Medicinal composition for treating hypertension and preparing method thereof |
| 04/14/2004 | CN1488382A Health-care medicine for preventing and curing cardio-cerebrovascular diseae |
| 04/14/2004 | CN1488381A Artichoke leaf cream extracting technique |
| 04/14/2004 | CN1488380A Use of chinese medicine composition in preparing medicine for anti SARS virus |
| 04/14/2004 | CN1488379A Tenuifolia volatile oil, and formulation preparing method and use in preparing medicine for anti-cold thereof |
| 04/14/2004 | CN1488378A SARS epidemic-removing pill |
| 04/14/2004 | CN1488377A External-use medicine for treating skin wound, scab and infection |
| 04/14/2004 | CN1488376A Medicinal cap sule for treating enteric disease and nusosinusitis and preparing method thereof |
| 04/14/2004 | CN1488363A Method for manufacturing medical health-care beauty article |